• SENSEX 78,594.02
    94.85 (+0.12%)
  • BANKNIFTY 57,746.45
    -317.20 (--0.55%)
  • Hitachi Energy
    35,800.00 38,800.00(%)
  • Sun Pharma.Inds.
    1,965.00 2,047.55(%)
  • HDFC Bank
    737.40 1,020.35(%)
  • Kaynes Tech
    3,530.70 2,995.85(%)
  • Cupid
    256.55 31.84(%)
  • GE Vernova T&D
    4,136.20 2,525.00(%)
  • SBI
    1,078.60 790.10(%)
  • Electronics Mart
    189.75 171.25(%)
  • Titan Company
    5,097.10 5,033.80(%)
  • Kalyan Jewellers
    619.50 649.00(%)
  • Netweb Technol.
    5,084.00 5,241.65(%)
  • EID Parry
    785.00 698.40(%)
  • Shivalik Bimetal
    1,042.00 920.25(%)
  • Cipla
    1,449.50 1,165.55(%)
  • Infosys
    1,195.00 1,727.85(%)
  • Hero Motocorp
    5,930.00 6,390.00(%)
  • Ather Energy
    1,520.00 1,507.30(%)
  • ICICI Bank
    1,415.60 1,187.55(%)
  • Vedanta Oil and Gas
    39.29 47.67(%)
  • Vedanta
    285.70 360.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gujarat Themis Biosyn Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Themis
  • BSE Code : 216.0
  • ISIN : INE942C01045
355.95 -6 (-1.64%)
  • As on 10 Aug 2026 (EOD)

  • Today’s Low

    341.65

  • Today’s High

    382.20

  • Open

    364.80

  • Perv Close

    361.90

  • 52W Low

    225.05

  • 52W High

    479.00

Key Indicators

  • P/E(TTM)

    83.29

  • Mar.Cap (₹Cr.)

    3,878.62

  • Div & Yield %

    0.19

  • Book Value(₹)

    26.41

  • Debt-Equity Ratio

    -1.64

  • AGM Date

    07-Aug-2026

  • EPS

    4.28

  • P/E Ratio

    83.29

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    3,878.62

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.90

  • BV (₹)

    26.40

  • Sales( ₹ in Cr.)

    165.82

  • NP (in Cr.)

    46.68

  • NP Var(%)

    -4.0

  • Div%

    67.0

  • CPS (₹)

    5.50

  • EPS (₹)

    4.30

  • Traded Value (₹ in Lakhs)

    3,884.61

  • 52 Week High

    479.00

  • 52 Week Low

    225.05

  • Price BSE

    357.0

  • Price NSE

    356.00

  • Market Capital( in Cr.)

    3,884.61

  • P/C Ratio

    65.30

  • P/E Ratio

    83.30

  • Price Vs.BV

    4.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 150.80 169.82 148.39 114.85 90.56 85.12
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 150.80 169.82 148.39 114.85 90.56 85.12
Other Income 1.68 4.38 6.59 4.05 3.27 1.70
Stock Adjustments 1.27 -11.01 3.24 5.13 0.38 4.11
Total Income 153.75 163.19 158.22 124.03 94.21 90.93
EXPENDITURE :            
Raw Materials 25.78 25.67 29.73 21.75 15.75 15.44
Power and Fuel Cost 26.63 26.53 26.41 21.73 16.57 22.86
Employee Cost 11.44 10.21 7.75 7.08 7.11 6.43
Other Manufacturing Expenses 8.44 6.79 6.80 7.91 8.79 10.53
Selling and Administration Expenses 5.81 8.59 6.66 2.31 1.86 1.64
Miscellaneous Expenses 4.36 2.29 0.64 1.15 0.53 0.49
Employee Benefit Expenses 11.44 10.21 7.75 7.08 7.11 6.43
Less: Preoperative Expenditure -0.01 -0.01 0.00 0.00 0.00 0.00
Total Expenses 82.48 80.09 77.99 61.94 50.61 57.39
Operating Profit 71.27 83.10 80.22 62.10 43.59 33.54
Interest 0.36 0.23 0.18 0.83 0.98 0.92
Gross Profit 70.91 82.87 80.04 61.27 42.61 32.62
Depreciation 5.37 3.54 2.58 2.23 1.73 1.36
Profit Before Tax 65.54 79.33 77.46 59.04 40.88 31.26
Current Tax 16.49 19.80 19.24 15.34 10.58 7.64
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.28 0.38 0.26 0.07 0.13 -0.05
Reported Net Profit 48.77 59.16 57.97 43.62 30.18 23.67
Extraordinary Items 0.00 0.00 0.00 0.00 0.01 0.62
Adjusted Net Profit 48.77 59.16 57.97 43.62 30.17 23.05
Adjustment below Net Profit -1.42 -0.03 0.06 -0.08 -0.03 0.00
P & L Balance brought forward 191.79 139.56 93.74 60.36 32.61 8.93
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.82 6.90 12.20 10.17 2.40 0.00
P & L Balance carried down 237.33 191.79 139.56 93.74 60.36 32.61
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 67.00 100.00 108.00 220.00 0.00 33.00
Dividend Per Share(Rs) 0.67 1.00 5.40 11.00 0.00 1.65
Earnings Per Share-Unit Curr 4.48 8.14 39.90 30.03 20.77 16.30
Earnings Per Share(Adj)-Unit Curr 4.48 5.43 5.32 4.00 2.77 2.17
Book Value 22.79 27.72 102.66 71.11 48.14 29.04
Book Value(Adj)-Unit Curr 22.79 18.48 13.69 9.48 6.42 3.87

Shareholding Pattern

  • Promoter Group

    70.86%

  • Public Share Holding

    29.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 74,014,847 67.93 74,014,847 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,203,236 2.94 3,203,231 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 77,218,083 70.86 77,218,078 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 750 0.00 750 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 250 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,924,385 1.77 1,924,385 16
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,269,299 1.16 1,255,299 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 11,250 0.01 1,000 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,205,934 2.94 3,181,434 25
2] Non Institution
Bodies Corporate 3,510,689 3.22 3,483,689 166
Clearing Members 96,265 0.09 96,265 17
Directors of their Relatives 169,770 0.16 169,770 1
Employees 0 0.00 0 0
Escrow Account 598,176 0.55 597,926 2
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,312,388 1.20 1,177,138 756
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,410,338 1.29 1,410,338 494
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,658,058 4.27 4,658,058 11
Individuals holding nominal share capital up to Rs. 1 lakh 16,545,083 15.18 15,583,498 25,502
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,000 0.00 750 2
Others 1,000 0.00 750 2
Sub Total 28,541,248 26.19 27,416,663 26,976
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 108,965,265 100.00 107,816,175 27,010

Company Background

Gujarat Themis Biosyn LtdPharmaceuticals - Indian - Bulk Drugs

  • Gujarat Themis Biosyn Ltd
  • BSE Code : 216.0
  • ISIN : INE942C01045

  • Incorporation Year

    1981

  • Registered Office

    69/C GIDC Industrial Estate
    Valsad Dist, VAPI,
    Gujarat-396195

  • Telephone

    91-260-2430027

  • FAX

    91-260-2400639

  • Chairman

    Dinesh S Patel

  • Managing Director

    Sachin D Patel

  • Company Secretary

  • Auditor

    GMJ & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Gujarat Themis Biosyn Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Guj. Themis Bio. 356.50 152.47 150.80 83.29 27.21
Abbott India 27,780.40 7,217.19 6,929.05 38.04 43.78
Astrazeneca Phar 8,188.15 2,304.07 2,275.58 109.16 27.86
P & G Health Ltd 6,149.35 944.52 934.17 31.22 71.75
Glaxosmi. Pharma 2,593.05 3,932.76 3,790.20 41.42 58.17
Novartis India 1,609.90 398.23 356.27 40.65 16.64
Cipla 1,472.00 20,102.60 18,979.95 38.69 13.88
Fermenta Biotec. 559.55 474.15 450.25 25.62 18.77
Amrutanjan Healt 522.95 469.50 451.82 26.11 21.89
Bliss GVS Pharma 477.10 773.53 729.81 52.31 12.51
Ambalal Sarabhai 46.63 19.52 3.94 32.61 6.77